Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib + Chemotherapy in Elderly Ph+ ALL
NCT01528085Phase 2Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Jan 2012
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of nilotinib in Acute lymphoblastic leukemia, Philadelphia chromosome positive, sponsored by Goethe University Frankfurt. Started Jan 2012; status: completed.
02
Drugs
nilotinib
03
Conditions
Acute lymphoblastic leukemia, Philadelphia chromosome positive
Beyond the preview
Go deeper on NCT01528085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528085.